Filing Details

Accession Number:
0001209191-21-058521
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-01 17:12:47
Reporting Period:
2021-09-01
Accepted Time:
2021-10-01 17:12:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1684087 Caroline Young 2525 West End Avenue
Suite 950
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-01 15 $2.88 13,373 No 4 P Direct
Common Stock Acquisiton 2021-09-02 15 $2.88 13,388 No 4 P Direct
Common Stock Acquisiton 2021-09-03 15 $2.85 13,403 No 4 P Direct
Common Stock Acquisiton 2021-09-07 15 $2.79 13,418 No 4 P Direct
Common Stock Acquisiton 2021-09-08 15 $2.89 13,433 No 4 P Direct
Common Stock Acquisiton 2021-09-09 15 $2.77 13,448 No 4 P Direct
Common Stock Acquisiton 2021-09-10 15 $2.78 13,463 No 4 P Direct
Common Stock Acquisiton 2021-09-13 15 $2.96 13,478 No 4 P Direct
Common Stock Acquisiton 2021-09-14 15 $3.02 13,493 No 4 P Direct
Common Stock Acquisiton 2021-09-15 15 $2.86 13,508 No 4 P Direct
Common Stock Acquisiton 2021-09-16 15 $2.91 13,523 No 4 P Direct
Common Stock Acquisiton 2021-09-17 15 $2.85 13,538 No 4 P Direct
Common Stock Acquisiton 2021-09-20 15 $2.82 13,553 No 4 P Direct
Common Stock Acquisiton 2021-09-21 15 $2.81 13,568 No 4 P Direct
Common Stock Acquisiton 2021-09-22 15 $2.76 13,583 No 4 P Direct
Common Stock Acquisiton 2021-09-23 15 $2.75 13,598 No 4 P Direct
Common Stock Acquisiton 2021-09-24 15 $2.74 13,613 No 4 P Direct
Common Stock Acquisiton 2021-09-27 15 $2.79 13,628 No 4 P Direct
Common Stock Acquisiton 2021-09-28 15 $2.76 13,643 No 4 P Direct
Common Stock Acquisiton 2021-09-29 15 $2.82 13,658 No 4 P Direct
Common Stock Acquisiton 2021-09-30 15 $2.72 13,673 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.